Urgent.News

What's breaking now, across thousands of outlets.

Business

Editor’s pick: Excelsior Sciences

Nature Biotechnology, Published online: 03 August 2026; doi:10.1038/s41587-026-03249-3 Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Excelsior Sciences is developing a closed-loop system for drug discovery using carbon building bloccs.

We haven't written up this one. Nature Biotechnology has the full story — the link below goes straight to it.

Read the original at nature.com →

More in Business

More from Monday 3 August →